A nine-day accelerated radiation protocol for feline squamous cell carcinoma

Veterinary Radiology and Ultrasound

Volumn 48, Issue 5, 2007, Pages 482-485

  Fidel, Janean L ^a   Sellon, Rance K ^a   Houston, Robert K ^a   Wheeler, Betsy A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Accelerated therapy; Cats; Hypofractionated; Oral tumors; Squamous cell carcinoma

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FEMALE; MALE; MORTALITY; MOUTH TUMOR; PATHOLOGY; RADIATION DOSE; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; FEMALE; MALE; MOUTH NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

FELIDAE;

EID: 34548286363     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2007.00283.x     Document Type: Article

References (29)

1. Stebbins KE, Morse CC, Goldschmidt MH. Feline oral neoplasia: a ten-year survey. Vet Pathol 1989 26:121 128.
2. Bradley RL, MacEwen EG, Loar AS. Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. J Am Vet Med Assoc 1984 184:460 463.
3. O'Brien MG, Withrow SJ, Straw RC, et al. Total and partial orbitectomy for the treatment of periorbital tumors in 24 dogs and 6 cats: a retrospective study. Vet Surg 1996 25:471 479.
4. Hutson CA, Willauer CC, Walder EJ, et al. Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989). J Am Vet Med Assoc 1992 201:777 781.
5. Fox LE, Rosenthal RC, King RR, et al. Use of cis-bis-neodecanoato-trans- R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma. Am J Vet Res 2000 61:791 795.
6. Ogilvie GK, Moore AS, Obradovich JE, et al. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. J Am Vet Med Assoc 1993 202:1839 1844.
7. Mauldin GN, Matus RE, Patnaik AK, et al. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. J Vet Intern Med 1988 2:60 65.
8. Buhles WC Jr., Theilen GH. Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma. Am J Vet Res 1973 34:289 291.
9. Couto CG, Hammer AS. Oncology. In:Sherding RG (ed):The cat: diseases and clinical management, 2nd ed. New York:Churchill Livingstone, 1994 755 818.
10. Hayes A, Scase T, Miller J, et al. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J Comp Pathol 2006 135:93 99.
11. Carroll GL, Simonson SM. Recent developments in nonsteroidal antiinflammatory drugs in cats. J Am Anim Hosp Assoc 2005 41:347 354.
12. LaRue SM, Gillette EL. Chapter 10, radiation therapy. In:Withrow SJ, MacEwen EG (eds):Small animal clinical oncology, 3rd ed. New York:W. B. Saunders Company, 2001 119 137.
13. Schantz SP, Harrison LB, Forastiere AA. Chapter 30, section 2, tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity and oropharynx. In:Vincent J, Devita T, Hellman S, Rosenberg SA (eds):Cancer - principles and practice of oncology, 6th ed. Philadelphia:Lippincott Williams & Wilkins, 2001 797 860.
14. Postorino-Reeves NCTJ, Withrow SJ. Oral squamous cell carcinoma in the cat. J Am Vet Med Assoc 1993 202:438 441.
15. Bregazzi VS, LaRue SM, Powers BE, et al. Response of feline oral squamous cell carcinoma to palliative radiation therapy. Vet Radiol Ultrasound 2001 42:77 79.
16. Jones PD, de Lorimier LP, Kitchell BE, et al. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma. J Am Anim Hosp Assoc 2003 39:463 467.
17. Larue SM, Vail DM, Ogilvie GK, Powers BE, Withrow SJ. Shrinking-field radiation therapy in combination with mitoxantrone chemotherapy for the treatment of oral squamous cell carcinoma in the cat. 11th Annual Conference of the Veterinary Cancer Society, Minneapolis, MN, 1991; 99.
18. LeBlanc AK, LaDue TA, Turrel JM, et al. Unexpected toxicity following use of gemcitabine as a radiosensitizer in head and neck carcinomas: a veterinary radiation therapy oncology group pilot study. Vet Radiol Ultrasound 2004 45:466 470.
19. Hall EJ. Chapter 6, the oxygen effect and reoxygenation. In:Hall EJ (ed):Radiobiology for the radiologist, 5th ed. Philadelphia:Lippincott Williams & Wilkins, 2000 91 111.
20. Evans SM, LaCreta F, Helfand S, et al. Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1991 20:703 708.
21. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer - the time factor. Int J Radiat Oncol Biol Phys 1997 39:831 836.
22. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000 47:1 12.
23. Nguyen LN, Ang KK. Radiotherapy for cancer of the head and neck: altered fractionation regimens. Lancet Oncol 2002 3:693 701.
24. Schwyn U, Crompton NE, Blattmann H, et al. Potential tumour doubling time: determination of Tpot for various canine and feline tumours. Vet Res Commun 1998 22:233 247.
25. Melzer K, Guscetti F, Rohrer Bley C, et al. Ki67 reactivity in nasal and periocular squamous cell carcinomas in cats treated with electron beam radiation therapy. J Vet Intern Med 2006 20:676 681.
26. Owens LM. TNM classification of tumors in domestic animals, 1st ed. Geneva:World Health Organization, 1980.
27. Ladue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound 2001 42:475 476.
28. Hall EJ. Time, dose, and fractionation in radiotherapy. Radiobiology for the radiologist. Philidelphia, PA:Lippincott Williams & Wilkins, 2000 397 418.
29. Fidel JL, Egger E, Blattmann H, et al. Proton irradiation of feline nasal planum squamous cell carcinomas using an accelerated protocol. Vet Radiol Ultrasound 2001 42:569 575.